Annual Current Liabilities
$11.40 M
+$172.90 K+1.54%
December 31, 2022
Summary
- As of February 10, 2025, ADMP annual total current liabilities is $11.40 million, with the most recent change of +$172.90 thousand (+1.54%) on December 31, 2022.
- During the last 3 years, ADMP annual current liabilities has risen by +$1.99 million (+21.11%).
Performance
ADMP Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Current Liabilities
$15.01 M
+$2.06 M+15.90%
June 30, 2023
Summary
- As of February 10, 2025, ADMP quarterly total current liabilities is $15.01 million, with the most recent change of +$2.06 million (+15.90%) on June 30, 2023.
- Over the past year, ADMP quarterly current liabilities has increased by +$5.28 million (+54.33%).
Performance
ADMP Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ADMP Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | +1.5% | +54.3% |
3 y3 years | +21.1% | +21.4% |
5 y5 years | +29.7% | +34.8% |
ADMP Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | at high | -1.5% | at high | -40.9% |
5 y | 5-year | -42.8% | -17.4% | -29.6% | -40.9% |
alltime | all time | -42.8% | -97.7% | -29.6% | -99.3% |
Adamis Pharmaceuticals Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Jun 2023 | - | $15.01 M(+15.9%) |
Mar 2023 | - | $12.95 M(+13.6%) |
Dec 2022 | $11.40 M(+1.5%) | $11.40 M(+28.4%) |
Sep 2022 | - | $8.87 M(-8.7%) |
Jun 2022 | - | $9.72 M(-28.4%) |
Mar 2022 | - | $13.58 M(+21.0%) |
Dec 2021 | $11.22 M(-43.7%) | $11.22 M(+22.0%) |
Sep 2021 | - | $9.20 M(-31.6%) |
Jun 2021 | - | $13.45 M(-36.9%) |
Mar 2021 | - | $21.32 M(+7.0%) |
Dec 2020 | $19.93 M(+111.8%) | $19.93 M(+53.5%) |
Sep 2020 | - | $12.98 M(+4.9%) |
Jun 2020 | - | $12.37 M(+16.8%) |
Mar 2020 | - | $10.59 M(+12.5%) |
Dec 2019 | $9.41 M(-18.6%) | $9.41 M(-13.2%) |
Sep 2019 | - | $10.83 M(-5.5%) |
Jun 2019 | - | $11.46 M(+0.6%) |
Mar 2019 | - | $11.40 M(-1.4%) |
Dec 2018 | $11.55 M(+31.5%) | $11.55 M(-2.8%) |
Sep 2018 | - | $11.88 M(+6.7%) |
Jun 2018 | - | $11.14 M(+50.7%) |
Mar 2018 | - | $7.39 M(-15.9%) |
Dec 2017 | $8.79 M(+2.1%) | $8.79 M(+30.3%) |
Sep 2017 | - | $6.74 M(+4.5%) |
Jun 2017 | - | $6.45 M(-28.6%) |
Mar 2017 | - | $9.04 M(+5.0%) |
Dec 2016 | $8.61 M(+213.4%) | $8.61 M(-2.2%) |
Sep 2016 | - | $8.80 M(-38.6%) |
Jun 2016 | - | $14.33 M(+261.8%) |
Mar 2016 | - | $3.96 M(+44.2%) |
Dec 2015 | $2.75 M(-19.0%) | $2.75 M(+23.2%) |
Sep 2015 | - | $2.23 M(+6.3%) |
Jun 2015 | - | $2.10 M(-7.7%) |
Mar 2015 | - | $2.28 M(-1.9%) |
Dec 2014 | $3.39 M(+15.7%) | - |
Sep 2014 | - | $2.32 M(+21.7%) |
Jun 2014 | - | $1.91 M(-35.0%) |
Mar 2014 | $2.93 M(-37.3%) | $2.93 M(-37.1%) |
Dec 2013 | - | $4.67 M(-44.8%) |
Sep 2013 | - | $8.46 M(-6.9%) |
Jun 2013 | - | $9.09 M(+94.2%) |
Mar 2013 | $4.68 M(+61.7%) | $4.68 M(+12.3%) |
Dec 2012 | - | $4.16 M(-28.6%) |
Sep 2012 | - | $5.83 M(-3.5%) |
Jun 2012 | - | $6.05 M(+109.1%) |
Mar 2012 | $2.89 M(-7.1%) | $2.89 M(+15.5%) |
Dec 2011 | - | $2.50 M(+4.7%) |
Sep 2011 | - | $2.39 M(+25.0%) |
Jun 2011 | - | $1.91 M(-38.6%) |
Mar 2011 | $3.11 M(-37.1%) | $3.11 M(-7.3%) |
Dec 2010 | - | $3.36 M(-33.2%) |
Sep 2010 | - | $5.03 M(-12.7%) |
Jun 2010 | - | $5.75 M(+16.3%) |
Mar 2010 | $4.95 M | $4.95 M(+24.7%) |
Dec 2009 | - | $3.97 M(+13.9%) |
Sep 2009 | - | $3.49 M(+21.2%) |
Date | Annual | Quarterly |
---|---|---|
Jun 2009 | - | $2.88 M(+470.8%) |
Mar 2009 | - | $504.00 K(+96.4%) |
Dec 2008 | $256.60 K(-35.4%) | $256.60 K(+14.6%) |
Sep 2008 | - | $224.00 K(-14.5%) |
Jun 2008 | - | $262.00 K(-9.0%) |
Mar 2008 | - | $288.00 K(-27.5%) |
Dec 2007 | $397.30 K(-47.5%) | $397.30 K(+119.5%) |
Sep 2007 | - | $181.00 K(+28.4%) |
Jun 2007 | - | $141.00 K(-66.6%) |
Mar 2007 | - | $422.00 K(-44.2%) |
Dec 2006 | $756.10 K(-91.9%) | $756.10 K(-92.0%) |
Sep 2006 | - | $9.41 M(+12.2%) |
Jun 2006 | - | $8.38 M(-5.8%) |
Mar 2006 | - | $8.90 M(-5.3%) |
Dec 2005 | $9.39 M(+67.3%) | $9.39 M(+8.2%) |
Sep 2005 | - | $8.68 M(+170.4%) |
Jun 2005 | - | $3.21 M(-77.0%) |
Mar 2005 | - | $13.97 M(+148.9%) |
Dec 2004 | $5.61 M(+96.8%) | $5.61 M(+95.6%) |
Sep 2004 | - | $2.87 M(+3.5%) |
Jun 2004 | - | $2.77 M(-6.3%) |
Mar 2004 | - | $2.96 M(+3.7%) |
Dec 2003 | $2.85 M(+34.0%) | $2.85 M(+23.8%) |
Sep 2003 | - | $2.30 M(-5.0%) |
Jun 2003 | - | $2.42 M(+13.3%) |
Mar 2003 | - | $2.14 M(+0.5%) |
Dec 2002 | $2.13 M(+4.4%) | $2.13 M(+39.8%) |
Sep 2002 | - | $1.52 M(+14.4%) |
Jun 2002 | - | $1.33 M(-9.3%) |
Mar 2002 | - | $1.47 M(-28.0%) |
Dec 2001 | $2.04 M(-4.3%) | $2.04 M(+63.2%) |
Sep 2001 | - | $1.25 M(+33.4%) |
Jun 2001 | - | $936.00 K(-57.5%) |
Mar 2001 | - | $2.20 M(+3.4%) |
Dec 2000 | $2.13 M(+8.0%) | $2.13 M(+14.9%) |
Sep 2000 | - | $1.85 M(-13.0%) |
Jun 2000 | - | $2.13 M(+21.3%) |
Mar 2000 | - | $1.76 M(-11.0%) |
Dec 1999 | $1.97 M(-17.8%) | $1.97 M(+16.1%) |
Sep 1999 | - | $1.70 M(-5.6%) |
Jun 1999 | - | $1.80 M(-10.0%) |
Mar 1999 | - | $2.00 M(-16.7%) |
Dec 1998 | $2.40 M(+71.4%) | $2.40 M(+84.6%) |
Sep 1998 | - | $1.30 M(+116.7%) |
Jun 1998 | - | $600.00 K(-14.3%) |
Mar 1998 | - | $700.00 K(-50.0%) |
Dec 1997 | $1.40 M(+366.7%) | $1.40 M(+100.0%) |
Sep 1997 | - | $700.00 K(+600.0%) |
Jun 1997 | - | $100.00 K(-50.0%) |
Mar 1997 | - | $200.00 K(-33.3%) |
Dec 1996 | $300.00 K(-25.0%) | $300.00 K(+50.0%) |
Sep 1996 | - | $200.00 K(0.0%) |
Jun 1996 | - | $200.00 K(0.0%) |
Mar 1996 | - | $200.00 K(-50.0%) |
Dec 1995 | $400.00 K | $400.00 K(+100.0%) |
Sep 1995 | - | $200.00 K(-92.0%) |
Jun 1995 | - | $2.50 M |
FAQ
- What is Adamis Pharmaceuticals annual total current liabilities?
- What is the all time high annual current liabilities for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals annual current liabilities year-on-year change?
- What is Adamis Pharmaceuticals quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals quarterly current liabilities year-on-year change?
What is Adamis Pharmaceuticals annual total current liabilities?
The current annual current liabilities of ADMP is $11.40 M
What is the all time high annual current liabilities for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high annual total current liabilities is $19.93 M
What is Adamis Pharmaceuticals annual current liabilities year-on-year change?
Over the past year, ADMP annual total current liabilities has changed by +$172.90 K (+1.54%)
What is Adamis Pharmaceuticals quarterly total current liabilities?
The current quarterly current liabilities of ADMP is $15.01 M
What is the all time high quarterly current liabilities for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high quarterly total current liabilities is $21.32 M
What is Adamis Pharmaceuticals quarterly current liabilities year-on-year change?
Over the past year, ADMP quarterly total current liabilities has changed by +$5.28 M (+54.33%)